Few medical procedures in history have experienced a fall from scientific prestige as dramatic as the lobotomy. Once promoted as a revolutionary treatment for severe psychiatric illness, lobotomy later became a symbol of medical overreach, ethical failure, and inadequate scientific evidence. The controversy deepened further when Portuguese neurologist António Egas Moniz received the Nobel Prize in Physiology or Medicine for developing the procedure.
Today, the story of lobotomy still forces medicine to confront uncomfortable questions about psychiatric treatment, medical ethics, and the dangers of blindly trusting new scientific ideas. More importantly, it reflects a time when psychiatry had very few effective treatments, overcrowded mental hospitals were struggling to cope, and doctors were desperately searching for anything that could help their patients.
During the early twentieth century, mental healthcare systems across United States and Europe were overwhelmed with patients suffering from schizophrenia, severe depression, psychosis, bipolar disorder, and violent behavioral disturbances. Long-term institutionalization was common, and many psychiatric hospitals were overcrowded and understaffed.1
At the time, psychiatry lacked effective pharmacological treatments. Antipsychotics, antidepressants, and mood stabilizers had not yet been developed. Available therapies often included insulin coma therapy, electroconvulsive therapy, hydrotherapy, prolonged sedation, and physical restraint.2 In this environment of limited options and increasing desperation, psychosurgery emerged as a potential therapeutic breakthrough.
In 1935, Portuguese neurologist António Egas Moniz introduced a surgical technique called prefrontal leucotomy, later widely referred to as lobotomy. Moniz believed that psychiatric disorders were caused by abnormal neural connections within the frontal lobes of the brain.³ He theorized that severing these pathways could reduce emotional distress and stabilize behavior.
The procedure involved drilling openings into the skull and using a surgical instrument called a leucotome to cut white matter tracts connecting the frontal lobes. Moniz and his colleagues reported that several patients appeared calmer and less agitated after surgery.⁴ These early reports generated significant international attention, particularly because psychiatry at the time lacked reliable alternatives.
Although the evidence supporting the procedure was limited and methodologically weak, many physicians viewed lobotomy as a promising intervention for otherwise untreatable psychiatric illness.
To modern audiences, the widespread acceptance of lobotomy may appear shocking. However, within the context of 1930s and 1940s psychiatry, the procedure seemed to offer visible improvements in severely disturbed patients. Some individuals who had previously been violent, psychotic, or highly agitated became quieter and easier to manage after surgery.4
Psychiatric institutions facing overcrowding and staffing shortages often interpreted these behavioral changes as therapeutic success. As a result, lobotomy rapidly spread across Europe and the United States. Thousands of procedures were performed during the 1940s and early 1950s.5
Over time, lobotomy began to be seen not just as a treatment for mental illness, but also as a way to reduce the pressure on overcrowded psychiatric hospitals and make difficult patients easier to manage.
In 1949, António Egas Moniz was awarded the Nobel Prize in Physiology or Medicine “for his discovery of the therapeutic value of leucotomy in certain psychoses.”6 At the time, many believed psychosurgery represented a major advancement in psychiatric medicine.
However, the award later became one of the most debated decisions in Nobel history. Critics argued that the scientific evidence supporting lobotomy was inadequate, lacked proper long-term follow-up, and failed to fully document severe complications. Some historians have suggested that the Nobel Prize legitimized the procedure and accelerated its widespread global adoption.
Even decades later, the decision remains controversial because the award has never been revoked.
While Moniz developed the original surgical method, American neurologist Walter Freeman played the largest role in popularizing lobotomy in the United States. Freeman introduced the transorbital lobotomy, a simplified procedure performed through the eye socket using a long instrument resembling an ice pick.7
Unlike conventional neurosurgery, the transorbital technique could be performed quickly and often outside formal operating rooms. Freeman traveled extensively across the country performing demonstrations and promoting the surgery as an effective psychiatric treatment.
The simplicity and speed of the procedure contributed significantly to its rapid expansion, but they also increased concerns regarding patient safety and ethical oversight.
One of the most widely discussed examples of lobotomy’s devastating consequences was the case of Rosemary Kennedy, sister of President John F. Kennedy. In 1941, Rosemary underwent a lobotomy in an attempt to manage mood instability and behavioral difficulties.8
The procedure left her with severe and permanent cognitive disability. She lost much of her ability to communicate independently and required lifelong institutional care. Her case later became one of the strongest symbols of the ethical failures associated with psychosurgery.
Stories like Rosemary Kennedy’s forced both the medical community and the public to reconsider whether behavioral control had been mistaken for genuine treatment.
Although some patients appeared calmer after surgery, many experienced severe neurological and psychological complications. Reported adverse outcomes included:
emotional blunting
personality changes
cognitive impairment
memory loss
seizures
impaired judgment
apathy
loss of independence
In some cases, patients survived physically but experienced profound changes in personality and emotional functioning. Critics increasingly argued that the surgery often suppressed emotional expression rather than truly treating psychiatric illness.
As long-term follow-up data became available, confidence in lobotomy steadily declined.
The decline of lobotomy accelerated during the 1950s following the introduction of psychiatric medications such as Chlorpromazine. For the first time, physicians had access to less invasive treatments for psychosis and severe mental illness.
At the same time, growing awareness of the devastating side effects associated with lobotomy led to increasing criticism from neurologists, psychiatrists, and ethicists. Public opinion also shifted as media reports highlighted cases of permanent disability following surgery.
By the 1970s, lobotomy had largely disappeared from mainstream psychiatric practice and became widely regarded as a cautionary example in medical history.
Although lobotomy remains highly controversial, António Egas Moniz also played a major role in advancing neuroscience through his work on cerebral angiography, a technique that transformed the imaging and study of brain blood vessels.
As a result, his legacy continues to divide opinion. Some historians argue that Moniz was a product of a period when psychiatric medicine had very limited treatment options, while others see lobotomy as a warning about the risks of adopting medical innovations without sufficient scientific evidence or ethical safeguards.
The story of lobotomy highlights an important lesson in medical history: progress in medicine should never come at the cost of ethics, careful research, and the long-term well-being of patients.
António Egas Moniz, “The Nobel Prize in Physiology or Medicine 1949,”
João L. Rocha and Diogo Freitas, “Psychosurgery and the History of Lobotomy,”
António Egas Moniz, “Biographical,” Britannica.
Seye Abimbola, “The White Cut: Egas Moniz, Lobotomy, and the Nobel Prize,” BMJ 332, Suppl S1 (2006).
Walter Freeman and James Watts, “Psychosurgery,” discussed in Journal of Neurosurgery Focus.
Christopher Beam, “The Nobel-Winning Surgery That Destroyed Thousands of Lives,” The Washington Post.
Walter Freeman, discussed in The Journal of Neurosurgery.
“Rosemary Kennedy and the Tragic History of Her Lobotomy,” MedBound Times.
